Anti-Myosin light chain (phospho S20) 抗体 (ab2480)
製品の概要
-
製品名
Anti-Myosin light chain (phospho S20) antibody
Myosin light chain 一次抗体 製品一覧 -
製品の詳細
Rabbit polyclonal to Myosin light chain (phospho S20) -
由来種
Rabbit -
特異性
This phospho specific polyclonal antibody is specific for phosphorylated pS20 of human myosin light chain. Reactivity with non-phosphorylated human myosin light chain is less than 1% by ELISA. The selected peptide sequence used to generate the polyclonal antibody is located near the amino terminal end of the polypeptide corresponding to the smooth/non-muscle form of myosin regulatory light chain found in cardiac myocytes in addition to smooth and non-muscle cells. This sequence differs from that of the sarcomeric/cardiac form of myosin regulatory light chain that has a different sequence around the phosphorylation site. BLAST search analysis was used to determine that the smooth and non-muscle forms of myosin regulatory light chain have identical sequences. Cross reactivity is expected.
Customers have seen variable performance with Xenopus laevis.
-
アプリケーション
適用あり: ICC/IF, ELISA, WB, IHC-FoFr, IP, IHC-Pmore details -
種交差性
交差種: Mouse, Rat, Human, Caenorhabditis elegans
交差が予測される動物種: Bird, Mammals
-
免疫原
Human Myosin Light Chain phospho peptide corresponding to a region of the human protein conjugated to Keyhole Limpet Hemocyanin (KLH) - KKRPQRAT(pS)NVFAMFD (aa 12-27).
-
ポジティブ･コントロール
- Cardiac myocytes.
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle. -
バッファー
pH: 7.20
Preservative: 0.01% Sodium azide
Constituents: 0.42% Potassium phosphate, 0.87% Sodium chloride -
Concentration information loading... -
精製度
Immunogen affinity purified -
特記事項（精製）
This antibody was affinity purified from monospecific antiserum by immunoaffinity purification. Antiserum was first purified against the phosphorylated form of the immunizing peptide. The resultant affinity purified antibody was then cross-adsorbed against the non-phosphorylated form of the immunizing peptide. -
ポリ/モノ
ポリクローナル -
アイソタイプ
IgG -
研究分野
関連製品
-
Compatible Secondaries
-
Isotype control
アプリケーション
Our Abpromise guarantee covers the use of ab2480 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| アプリケーション | Abreviews | 特記事項 |
|---|---|---|
| ICC/IF | Use a concentration of 2.5 µg/ml. | |
| ELISA | 1/5000 - 1/20000. | |
| WB | 1/1000 - 1/5000. Predicted molecular weight: 20 kDa. We recommend using BSA for blocking when using phospho-specific antibodies. | |
| IHC-FoFr | Use at an assay dependent concentration. PubMed: 19279134 Trichloroacetic acid was used for tissue fixation. |
|
| IP | 1/100. | |
| IHC-P | Use at an assay dependent concentration. |
ターゲット情報
-
機能
Myosin regulatory subunit that plays an important role in regulation of both smooth muscle and nonmuscle cell contractile activity via its phosphorylation. Implicated in cytokinesis, receptor capping, and cell locomotion. -
組織特異性
Smooth muscle tissues and in some, but not all, nonmuscle cells. -
配列類似性
Contains 3 EF-hand domains. -
翻訳後修飾
Phosphorylation increases the actin-activated myosin ATPase activity and thereby regulates the contractile activity. It is required to generate the driving force in the migration of the cells but not necessary for localization of myosin-2 at the leading edge. - Information by UniProt
-
参照データベース
- Entrez Gene: 10398 Human
- Entrez Gene: 98932 Mouse
- Entrez Gene: 296313 Rat
- Omim: 609905 Human
- SwissProt: P24844 Human
- SwissProt: Q9CQ19 Mouse
- SwissProt: Q64122 Rat
- Unigene: 504687 Human
see all -
別名
- 20 kDa myosin light chain antibody
- KMLC antibody
- LC20 antibody
see all
画像
-
Western blot - Anti-Myosin light chain (phospho S20) antibody (ab2480)All lanes : Anti-Myosin light chain (phospho S20) antibody (ab2480) at 1/1000 dilution
Lane 1 : Regulatory Light Chain Non-Phospho recombinant protein, 50 ng
Lane 2 : Regulatory Light Chain Phospho recombinant protein, 50 ng
Lane 3 : Smooth Muscle Non-Phospho recombinant protein, 50 ng
Lane 4 : Smooth Muscle Phospho recombinant protein, 50 ng
Secondary
All lanes : Peroxidase rabbit secondary antibody at 1/40000 dilution
Predicted band size: 20 kDa -
Western blot - Anti-Myosin light chain (phospho S20) antibody (ab2480)Rabbit polyclonal to phospho Myosin Light Chain phospho Myosin Light Chain (Ser 20) (ab2480) used at a 1/5000 dilution to detect myosin light chain by Western blot. Either 13 ug (lanes 1-3) or 20 ug (lanes 4-7) of a mouse cardiac myocyte lysate was loaded on a 4-20% Criterion gel for SDS-PAGE. Samples were either mock-treated or CLA treated:
Lane 1 : untreated 45 min
Lane 2 : CLA 50 nm 45 min
Lane 3 : CLA 100 nm 45 min
Lane 4 : A21 untreated 45 min
Lane 5 : A22 A23187 5 min
Lane 6 : A23 A23187 15 min
Lane 7 : A24 A23187 60 min
After washing, a 1/5,000 dilution of anti-rabbit HRP (ab7090) was used as secondary.Rabbit polyclonal to phospho Myosin Light Chain phospho Myosin Light Chain (Ser 20) (ab2480) used at a 1/5000 dilution to detect myosin light chain by Western blot. Either 13 ug (lanes 1-3) or 20 ug (lanes 4-7) of a mouse cardiac myocyte lysate was loaded on a 4-20
-
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Myosin light chain (phospho S20) antibody (ab2480)IHC-P of ab2480 at 2.5 µg/ml staining both vascular and myometrial smooth muscle cells of the human uterus. The image shows localization of the antibody as the precipitated red signal, with a hematoxylin purple nuclear counterstain.
-
Immunocytochemistry/ Immunofluorescence - Anti-Myosin light chain (phospho S20) antibody (ab2480)Image from Barnhart EL et al., PLoS Biol. 2011 May;9(5):e1001059. doi: 10.1371/journal.pbio.1001059. Epub 2011 May 3. Fig 6.; May 3, 2011 PLoS Biology 9(5): e1001059.Immunofluroescence analysis of Nicaragua cichlid (Hypsophrys nicaraguensis) keratocytes, staining Myosin light chain (phospho S20) (green) with ab2480.
Cells were cultured on intermediate adhesion strength surfaces and extracted with 4% PEG and 1% Triton X-100 in cytoskeleton stabilizing buffer. Cells were blocked with PBS-BT for 5 minutes, and then incubated with primary antibody diluted in PBS-BT. Cells were then fixed with 4% formaldehyde in PBS for 10 minutes.
プロトコール
データシートおよび資料
参考文献
This product has been referenced in:
- Wang WY et al. Fibronectin promotes nasopharyngeal cancer cell motility and proliferation. Biomed Pharmacother 109:1772-1784 (2019). Read more (PubMed: 30551431) »
- Cavin S et al. Vascular-targeted low dose photodynamic therapy stabilizes tumor vessels by modulating pericyte contractility. Lasers Surg Med N/A:N/A (2019). Read more (PubMed: 30779366) »
